Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2018

NEXT STORY
Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases
PREV STORY
Asterias Announces Clinical Grade Lot Released to Support Dosing of First Subjects in First Clinical Study of AST-VAC2
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AzurRx BioPharma Reaches Enrollment Target for Phase II OPTION Clinical Trial

author_avatar
NASDAQ Market News

Innate Pharma presents preliminary data from TELLOMAK trial showing clinical response for lacutamab in mycosis fungoides

author_avatar
NASDAQ Market News

The global dPCR and qPCR market size is projected to reach USD 7.6 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 9.0%

author_avatar
NASDAQ Market News